A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way ...
A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return ...
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...
When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...
When COVID-19 vaccines first rolled out, pregnant women were largely left out of the original clinical trials, leaving them ...
Learn how mRNA and its lipid packaging change in the bloodstream, offering insights that could help researchers design better ...
A new mRNA flu vaccine promises a closer match to circulating flu strains. But dysfunction at federal health agencies is ...
Australian researchers have completed the first head-to-head comparison of three mRNA-lipid nanoparticle vaccine platforms in ...
For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug Administration approved the nation's first mRNA-based flu vaccine for use in people 50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results